Cell Therapy Nano
Nanotechnology for cell-based therapies
Nanobiotix
Paris, France
Clinical-stage biotechnology company pioneering nanomedicine with first-in-class radioenhancers for cancer treatment
Nanofiber Solutions
Columbus, United States
Developer of 3D nanofiber scaffolds for tissue engineering and cell culture applications
CytImmune Sciences
Rockville, United States
Developer of gold nanoparticle-based cancer therapeutics
Intellia Therapeutics
Cambridge, United States
Gene editing company using lipid nanoparticle delivery for in vivo CRISPR therapeutics
Prime Medicine
Cambridge, United States
Prime editing therapeutics with LNP delivery
Tidal Therapeutics
Cambridge, United States
LNP-based in vivo gene therapy for immune cells, acquired by Sanofi
NanoEnTek
Seoul, South Korea
Lab-on-a-chip and cell analysis systems
Brooks Automation
Chelmsford, United States
Automation and cryogenic solutions for semiconductors
CRISPR Therapeutics
Zug, Switzerland
CRISPR-based gene editing therapeutics for blood disorders and cancer
Editas Medicine
Cambridge, United States
CRISPR-based medicines for genetic diseases including eye disorders
Sphere Fluidics
Cambridge, United Kingdom
Picodroplet microfluidics for single-cell analysis and antibody discovery
Celgene (Bristol-Myers Squibb)
Summit, United States
Oncology and immunology therapeutics using nanoparticle formulations
Sumitomo Pharma
Osaka, Japan
Regenerative medicine and nanomedicine programs
Celltrion
Incheon, South Korea
Biosimilars and antibody drug conjugates
Nuvation Bio
New York, United States
Precision oncology with targeted drug development
Intellia Therapeutics
Cambridge, United States
CRISPR gene editing company using lipid nanoparticle delivery for in vivo therapeutics
Editas Medicine
Cambridge, United States
Genome editing company using CRISPR with lipid nanoparticle delivery systems
Verve Therapeutics
Cambridge, United States
Gene editing company for cardiovascular disease using base editing and LNP delivery
Selecta Biosciences
Watertown, United States
ImmTOR biodegradable nanoparticles for immune tolerance induction
Catalent
Somerset, United States
Contract manufacturer with lipid nanoparticle and advanced drug delivery capabilities
Lonza Pharma
Basel, Switzerland
Life sciences company with lipid nanoparticle manufacturing for mRNA therapeutics
Miltenyi Biotec
Bergisch Gladbach, Germany
Magnetic cell separation using superparamagnetic nanoparticles
STEMCELL Technologies
Vancouver, Canada
Cell separation and culture products using magnetic nanoparticle technology
Akadeum Life Sciences
Ann Arbor, United States
Microbubble technology for fast, gentle cell separation and enrichment
Sartorius
Göttingen, Germany
Bioprocess and lab equipment with nanofiltration and membrane technology
NanoCellect Biomedical
San Diego, United States
Microfluidic cell sorting for single-cell applications
Passage Bio
Philadelphia, United States
AAV gene therapies for CNS diseases with novel delivery
Spark Therapeutics
Philadelphia, United States
Gene therapy pioneer (Luxturna) now part of Roche
Bluebird Bio
Somerville, United States
Gene therapy using lentiviral vectors for genetic diseases
LogicBio Therapeutics
Lexington, United States
Gene insertion technology using AAV and GeneRide platform
Generation Bio
Cambridge, United States
Non-viral gene therapy using lipid nanoparticle delivery
Kernal Biologics
Cambridge, United States
Self-amplifying mRNA with immune-silent delivery
Orna Therapeutics
Cambridge, United States
Circular RNA platform for cell therapy and protein replacement
Entrada Therapeutics
Boston, United States
Endosomal Escape Vehicle (EEV) platform for intracellular delivery
Abzena
Cambridge, United Kingdom
ADC development and manufacturing CDMO
Sutro Biopharma
South San Francisco, United States
Cell-free protein synthesis for site-specific ADC conjugation
Prevail Therapeutics
New York, United States
Gene therapies for neurodegenerative diseases (Eli Lilly)
Sangamo Therapeutics
Brisbane, United States
Zinc finger nuclease gene editing and gene regulation
Regenxbio
Rockville, United States
AAV gene therapy using NAV Technology Platform
MeiraGTx
New York, United States
Gene therapy for inherited retinal diseases and beyond
Krystal Biotech
Pittsburgh, United States
Gene therapies using HSV-1 vectors for skin diseases
Sarepta Therapeutics
Cambridge, United States
Gene therapy and RNA therapeutics for muscular dystrophies
Ultragenyx Pharmaceutical
Novato, United States
Gene therapy and biologics for rare genetic diseases
Rocket Pharmaceuticals
Cranbury, United States
Lentiviral and AAV gene therapies for rare diseases
Lysogene
Paris, France
CNS-targeted gene therapy for lysosomal storage diseases
Freeline Therapeutics
Stevenage, United Kingdom
AAV gene therapy for liver-targeted diseases
Orchard Therapeutics
London, United Kingdom
Hematopoietic stem cell gene therapy for rare diseases
Synthego
Redwood City, United States
CRISPR reagent supplier and genome engineering platform
Poseida Therapeutics
San Diego, United States
Gene editing and CAR-T cell therapy using piggyBac system
Precision BioSciences
Durham, United States
ARCUS genome editing for cell therapy and gene correction
Cellectis
Paris, France
TALEN gene editing for allogeneic CAR-T cell therapy
Carisma Therapeutics
Philadelphia, United States
CAR-Macrophage therapy for solid tumors
Fate Therapeutics
San Diego, United States
iPSC-derived cell therapies including NK and T cells
BICO Group (Cellink)
Gothenburg, Sweden
Life science technology with bioprinting and bioinks for tissue engineering and drug discovery
Organovo
San Diego, United States
3D bioprinting pioneer developing human tissues for drug discovery and therapeutic applications
Aspect Biosystems
Vancouver, Canada
Microfluidic bioprinting for tissue therapeutics and drug delivery applications
Prellis Biologics
San Francisco, United States
Holographic bioprinting for vascularized tissues and organs at high speed and resolution
Biomarin Pharmaceutical
San Rafael, United States
Global biotechnology company developing therapies for rare genetic diseases
Vertex Pharmaceuticals
Boston, United States
Global biotechnology company focused on cystic fibrosis and gene editing therapies
Kite Pharma
Santa Monica, United States
Cell therapy company developing engineered autologous CAR T-cell cancer immunotherapies
Bristol Myers Squibb Cell Therapy
Summit, United States
Global biopharmaceutical company with leading CAR T cell therapy franchise
Legend Biotech
Somerset, United States
Global biotechnology company developing novel cell therapies for oncology
Allogene Therapeutics
South San Francisco, United States
Clinical-stage biotechnology company pioneering allogeneic CAR T cell therapies
Caribou Biosciences
Berkeley, United States
Clinical-stage CRISPR genome editing company developing transformative therapies
Lyell Immunopharma
South San Francisco, United States
T cell reprogramming company developing next-generation cell therapies for solid tumors
Adicet Bio
Menlo Park, United States
Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies
Century Therapeutics
Philadelphia, United States
Biotechnology company developing iPSC-derived allogeneic cell therapies for cancer
Takeda Cell Therapy
Tokyo, Japan
Global pharmaceutical company with advanced cell therapy programs
Berkeley Lights
Emeryville, United States
Digital cell biology company using optoelectronic positioning for single cell manipulation
Resilience
San Diego, United States
Biomanufacturing company building sustainable network for complex medicine production
Lonza Cell and Gene
Basel, Switzerland
Global CDMO providing cell and gene therapy manufacturing services
Catalent Cell and Gene
Somerset, United States
Global CDMO offering cell therapy, gene therapy, and viral vector manufacturing
Charles River Cell Solutions
Wilmington, United States
Contract research organization providing cell and gene therapy development services
WuXi Advanced Therapies
Shanghai, China
Global contract development and manufacturing organization for advanced therapies
Oxford Biomedica
Oxford, United Kingdom
Gene and cell therapy group specializing in lentiviral vector development and manufacturing
uniQure
Amsterdam, Netherlands
Gene therapy company developing AAV-based treatments for severe genetic diseases
Rocket Pharmaceuticals
Cranbury, United States
Gene therapy company developing treatments for rare childhood diseases
Abeona Therapeutics
New York, United States
Clinical-stage biopharmaceutical company developing gene therapies for rare diseases
LogicBio Therapeutics
Lexington, United States
Genome editing company developing gene insertion medicines for pediatric diseases
Lexeo Therapeutics
New York, United States
Gene therapy company developing treatments for cardiac and neurological diseases
Sana Biotechnology
Seattle, United States
Biotechnology company engineering cells to treat disease using in vivo and ex vivo approaches
TransMedics
Andover, United States
Medical technology company developing organ care system for transplantation
AngioDynamics
Latham, United States
Medical device company developing minimally invasive medical devices
Upside Foods
Berkeley, United States
Cultivated meat company growing real meat directly from animal cells
GOOD Meat
Alameda, United States
Eat Just subsidiary producing cultivated chicken meat approved for sale
Aleph Farms
Rehovot, Israel
Cultivated steak company growing beef directly from non-GMO cells
Mosa Meat
Maastricht, Netherlands
Cultivated beef company from the creator of the first cultured hamburger
SuperMeat
Tel Aviv, Israel
Cultivated chicken company developing cell-cultured poultry
Finless Foods
Emeryville, United States
Cultivated seafood company growing bluefin tuna from cells
BlueNalu
San Diego, United States
Cultivated seafood company producing cell-based fish products
Wildtype
San Francisco, United States
Cultivated salmon company growing sushi-grade salmon from cells
Cellino
Cambridge, United States
AI-guided laser platform for personalized cell therapy manufacturing
Cour Pharmaceutical
Chicago, United States
Particle platforms enabling immune targeting for inflammatory and immune applications
Evox Therapeutics
Oxford, United Kingdom
DeliverEX platform for engineered exosome therapeutics